16.35
1.09%
-0.18
Precedente Chiudi:
$16.53
Aprire:
$16.5
Volume 24 ore:
168.69K
Capitalizzazione di mercato:
$417.49M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.94%
1M Prestazione:
-7.63%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Lenz Therapeutics Inc Stock (LENZ) Company Profile
Nome
Lenz Therapeutics Inc
Settore
Industria
Telefono
(650) 484-0886
Indirizzo
611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO
Lenz Therapeutics Inc Borsa (LENZ) Ultime notizie
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director James W. Mccollum Acquires 31332 Shares - Defense World
Defense World
Lenz Therapeutics CFO purchases $49987 in company stock - Investing.com India
Investing.com India
Lenz Therapeutics CFO purchases $49,987 in company stock By Investing.com - Investing.com Canada
Investing.com Canada
Insider Buying: LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director Acquires 31,332 Shares of Stock - MarketBeat
MarketBeat
Lenz therapeutics director McCollum buys $501k in stock - Investing.com
Investing.com
FY2024 EPS Estimates for LENZ Therapeutics, Inc. (NASDAQ:LENZ) Reduced by William Blair - MarketBeat
MarketBeat
Lenz Therapeutics Inc Azioni (LENZ) Dati Finanziari
Non sono disponibili dati finanziari per Lenz Therapeutics Inc (LENZ). Controlla altri titoli per ulteriori informazioni.
Lenz Therapeutics Inc Azioni (LENZ) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
MCCOLLUM JAMES W | Director |
May 13 '24 |
Buy |
15.99 |
31,332 |
501,093 |
525,565 |
RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 21 '24 |
Buy |
15.03 |
998,009 |
15,000,075 |
3,319,339 |
Capitalizzazione:
|
Volume (24 ore):